Delivery Order SPE2DE24D0013-SPE2D626F01NF
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $4,620 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated XPRS-COV2-10, represents a child contract issued under Cepheid's broader Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December...
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's broader indefinite delivery vehicle with the Department of Veterans Affairs VISN 6, valued at $32.8M and extending through September 30, 2030. The award carries no set-aside designation and is for the provision of...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,024.00 under contract XPRSTREPA-10 by the Defense Logistics Agency's Medical Supply Chain on January 11, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order, which is a child contract with no set-aside designation, represents a specific procurement action for diagnostic testing supplies under Cepheid's larger indefinite delivery contract framework with...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F01NFDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $4,416.00 delivery order on January 12, 2026, under contract number XPRSTREPA-10, with performance completion targeted for January 20, 2026. This firm fixed-price delivery order, which is not set-aside designated, represents a child contract under Cepheid's larger indefinite delivery vehicle with the Department of Veterans Affairs and reflects continued procurement of molecular diagnostic solutions. The order will be performed at Cepheid's headquarters in Sunnyvale, California, and aligns with the company's established role as a primary federal supplier of diagnostic reagents and test kits for the GeneXpert diagnostic platform. This delivery order is part of Cepheid's extensive federal contracting portfolio, which includes two significant IDC vehicles with the VA valued at $6.7M and $32.8M respectively, extending through 2029-2030. Cepheid specializes in rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions, serving multiple federal healthcare agencies including the Veterans Health Administration, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The modest contract value reflects a routine procurement cycle within Cepheid's broader engagement as a core molecular diagnostics supplier supporting federal healthcare laboratory operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/11/26 |